Close X
Attorney Spotlight

Learn about Richard Arnholt's diverse government contracts practice and why he chose to pursue a career in the legal field. Read more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

In June 2017, Pinnacle Financial Partners, Inc. (NASDAQ: PNFP) closed a $1.9 billion merger with BNC Bancorp (NASDAQ: BNCN) pursuant to which BNC merged with and into Pinnacle. With the completion of the transaction, Pinnacle becomes a Top 50 U.S. Bank. The merger will create a four state footprint concentrated in 12 of the largest urban markets in the Southeast. 

Bass, Berry & Sims has served Pinnacle as primary corporate and securities counsel for more than 15 years and served as counsel on the transaction. Our attorneys were involved in all aspects related to the agreement, including tax, employee benefits and litigation. 

Read more details about the transaction here.

Pinnacle Financial Partners logo

Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

Regulation A+

It seems that lately there has been a noticeable uptick in Regulation A+ activity, including several recent Reg A+ securities offerings where the stock now successfully trades on national exchanges. In light of this activity, we have published a set of FAQs about Regulation A+ securities offerings to help companies better understand this "mini-IPO" offering process, as well as pros and cons compared to a traditional underwritten IPO.

Read now

Antitrust Agencies Challenge Another Healthcare Provider Acquisition - Update

Publications

April 3, 2013

Last summer we issued an alert regarding the FTC and Nevada AG's challenge to Reno, Nev.-based Renown Health's acquisition of two cardiology practices.[1] The challenge ensued because the acquisition at issue resulted in Renown allegedly having 88 percent of the cardiologists in the Reno area. At the time, we reported that Renown entered into a consent decree that required Renown to suspend non-compete agreements until a certain number of cardiologists in the acquired practices left Renown's employment. In addition, Renown was required to notify the agencies of any future cardiology-related acquisitions, and to reimburse the investigation costs of the State of Nevada (something state AG's frequently demand).

After an internal investigation by outside antitrust counsel, Renown Health announced yesterday the immediate departure of four executives, including Renown's CEO, its general counsel, VP of system development, and business development administrator. As stated by Renown's board of directors in the announcement:

"There is no question that things did not go as planned," said Renown Health board chairman David C. Line, "and for that we are sincerely sorry. As an organization, we have been committed to taking whatever steps are necessary to make sure that our policies, procedures and communications are as world-class as the health care we provide. If the execution of the SNCA transaction had been as solid as our intentions, none of this would have occurred."

This is another example not only of the increase in antitrust enforcement in the healthcare industry by the federal and state antitrust authorities, but the collateral consequences that can follow an enforcement action. This also demonstrates the need for an effective compliance program.

If you have any questions about the content of this alert or antitrust issues, please contact one of the Bass Berry & Sims' attorneys listed here.

________________________________________
[1] A copy of the prior alert can be found here.


Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.